Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, ...

ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

The global ApheresisMarket features a highly competitive vendor landscape, with few large vendors holding massive share in the overall market, observes Transparency Market Research. The high costs ...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT launched the Correct Connect System, a new, standardized connection system for the solutions used during apheresis procedures. The Correct Connect system ...

Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...

Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases. Increasing Demand for Source Plasma From Biopharmaceutical Companies. Rising Demand for Blood Components and ...

Apheresis for Leukemia and Pediatric Patients. Emerging Economies With Increasing Investments From Government Bodies and Leading Players. This study involved the extensive use of both primary and ...

CHICAGO, April 12, 2024 /PRNewswire/ -- Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from ...